Torasemide

규격

56211-40-6CAS 번호

637-197-3EC 번호

1-[[4-(3-methylanilino)-3-pyridinyl]sulfonyl]-3-propan-2-ylureaIUPAC 명칭

C16H20N4O3S화학식

348.4 g/mol분자량

Torasemide; TORSEMIDE; 56211-40-6; Luprac; Torasemida; Torasemidum; BM-02015; AC-4464; Soaanz; Upcard; JDL 464; AC4464; DTXSID2023690; AC 4464; Torasemide anhydrous; 1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea; BM 02015; BM02.015; N-(((1-Methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-3-pyridinesulfonamide; W31X2H97FB; BM-02.015; 3-Pyridinesulfonamide, N-(((1-methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-; CHEBI:9637; DTXCID203690; 3-Pyridinesulfonamide, N-[[(1-methylethyl)amino]carbonyl]-4-[(3-methylphenyl)amino]-; 1-{4-[(3-methylphenyl)amino]pyridine-3-sulfonyl}-3-(propan-2-yl)urea; n-[[(1-methylethyl)amino]carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide; 1-(4-((3-methylphenyl)amino)pyridine-3-sulfonyl)-3-(propan-2-yl)urea; N-((4-((3-methylphenyl)imino)-1,4-dihydropyridin-3-yl)sulfonyl)propane-2-carbamimidic acid; N-({4-[(3-methylphenyl)imino]-1,4-dihydropyridin-3-yl}sulfonyl)propane-2-carbamimidic acid; 1-isopropyl-3-((4-(3-methylphenylamino)pyridine)-3-sulfonyl)urea; Torem 5; UpCArd-CA1; Torem 10; Torem 2.5; RefChem:57833; UpCArd-CA1 TORSEMIDE; C03CA04; Demadex; Torasemidum [INN-Latin]; Torasemida [INN-Spanish]; Unat; N-(Isopropylcarbamoyl)-4-(m-tolylamino)pyridine-3-sulfonamide; 1-[4-(3-methylanilino)pyridin-3-yl]sulfonyl-3-propan-2-ylurea; C16H20N4O3S; Torasemide [INN]; JDL-464; MLS001165687; Torasemide, Anhydrous; Torsemide [USAN]; NCGC00016879-01; SMR000466313; Toradiur; A1ATU; CAS-56211-40-6; N-[(isopropylamino)carbonyl]-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide; Dilutol; Torocard; Sutril; Torrem; Torasemide N; Torsemide (USP); Demadex (TN); GJ-1090; Luprac (TN); CCRIS 6736; Torasemide (JAN/INN); Torsemide [USAN:USP]; BRN 0498515; UNII-W31X2H97FB; Torsemid; NGBFQHCMQULJNZ-UHFFFAOYSA-N; Torasemide anhydrous; 1-(1-Methylethyl)-3-[[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl]urea; N-[[(1-Methylethyl)amino]carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide; Torsemide (Demadex); Torsemide (Standard); KS-1123; PW-2132; Spectrum_001776; TORSEMIDE [MI]; Torasemide anhydrous CRS; TORASEMIDE [JAN]; Prestwick0_001030; Prestwick1_001030; Prestwick2_001030; Prestwick3_001030; Spectrum2_001142; Spectrum3_001832; Spectrum4_000290; Spectrum5_001699; TORSEMIDE [VANDF]; TORASEMIDE [MART.]; TORSEMIDE [USP-RS]; CHEMBL1148; TORASEMIDE [WHO-DD]; SCHEMBL41184; BSPBio_001219; BSPBio_003503; KBioGR_000820; KBioSS_002257; cid_41781; MLS000759418; MLS001195611; MLS001424121; MLS006010744; BIDD:GT0623; SPECTRUM1505211; SPBio_001063; SPBio_003080; BPBio1_001341; GTPL7312; orb1224656; orb1308696; orb3025016; TORSEMIDE [ORANGE BOOK]; SCHEMBL29369134; SCHEMBL29395363; TORSEMIDE [USP IMPURITY]; BDBM64107; HY-B0247R; KBio2_002256; KBio2_004824; KBio2_007392; KBio3_003008; TORASEMIDE [EP MONOGRAPH]; TORSEMIDE [USP MONOGRAPH]; 1-isopropyl-3-[[4-(3-methylanilino)-3-pyridyl]sulfonyl]urea; GLXC-23564; HMS1571M21; HMS1922N05; HMS2051L21; HMS2098M21; HMS2234N14; HMS3373G20; HMS3393L21; HMS3715M21; HMS3744G19; HMS5087M17; ALBB-027267; HY-B0247; MSK10502; Tox21_110662; CCG-40257; EBC-06044; s1698; STL388026; Torasemide for system suitability CRS; Torsemide, >=98% (HPLC), solid; 1-({4-[(3-methylphenyl)amino]pyridin-3-yl}sulfonyl)-3-(propan-2-yl)urea; 4-[(3-methylphenyl)amino]-N-(propan-2-ylcarbamoyl)pyridine-3-sulfonamide; AKOS015894937; Tox21_110662_1; BM02015; DB00214; FT28331; NC00238; N-{[(1-methylethyl)amino]carbonyl}-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide; NCGC00016879-02; NCGC00016879-03; NCGC00016879-04; NCGC00016879-06; NCGC00016879-07; NCGC00095141-01; NCGC00095141-02; NCGC00095141-03; AC-18762; AB00514011; NS00000548; D00382; EN300-118719; AB00514011-09; AB00514011_10; AB00514011_11; F375846; Q419948; SR-01000759362; TORASEMIDE ANHYDROUS [EMA EPAR VETERINARY]; SR-01000759362-5; BRD-K30480208-001-05-2; BRD-K30480208-001-17-7; BRD-K30480208-001-18-5; Z1515385087; Torsemide, United States Pharmacopeia (USP) Reference Standard; 1-ISOPROPYL-3-((4-M-TOLUIDINO-3-PYRIDYL)SULPHONYL)UREA; 4-(3-methylanilino)-N-(propan-2-ylcarbamoyl)pyridine-3-sulfonamide; Torasemide anhydrous, European Pharmacopoeia (EP) Reference Standard; 4-(3-Methylanilino)-N-[(propan-2-yl)carbamoyl]pyridine-3-sulfonamide; N-(isopropylcarbamoyl)-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide; N-[(propan-2-yl)carbamoyl]-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide; Torasemide for system suitability, European Pharmacopoeia (EP) Reference Standard동의어